Blue Earth Therapeutics
UK - Oxford
PharmaceuticalFocus: Radiopharmaceuticals
Blue Earth Therapeutics is a life sciences company focused on Radiopharmaceuticals.
Neurology
Funding Stage
SERIES A
Open Jobs
0
Pipeline & Clinical Trials
Fluciclovine
Breast CancerClinical Trials (1)
NCT03036943Fluciclovine (18F) Imaging of Breast Cancer
N/A18F-rhPSMA-7.3
Prostate CancerClinical Trials (1)
NCT07011342Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
N/APelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT
Patients With Prostate CancerClinical Trials (1)
NCT03527199Prostate Cancer Patients With Biochemical Recurrence
N/AF-18 fluciclovine-PET/CT scan
Prostate AdenocarcinomaClinical Trials (1)
NCT03496844Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
N/AFluciclovine
Prostatic NeoplasmsClinical Trials (1)
NCT02443571Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
N/ADynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography
Metastatic Intracranial Malignant NeoplasmClinical Trials (1)
NCT0446241918F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain
N/APositron Emission Tomography
Prostate Cancer (Adenocarcinoma)Clinical Trials (1)
NCT06862856Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
N/A18F-Fluciclovine
Brain MetastasesClinical Trials (1)
NCT06015295A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
N/APSMA PET/CT scan
Prostate Cancer (Adenocarcinoma)Clinical Trials (1)
NCT07115914PSMA PET for Surveillance After Focal Therapy
N/A18F-fluciclovine
Advanced Prostate CancerClinical Trials (1)
NCT06062745Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1Biopsy of Prostate
Prostate CarcinomaClinical Trials (1)
NCT07164027Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Phase 1Axumin, Intravenous Solution
Glioma Glioblastoma MultiformeClinical Trials (1)
NCT03990285[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
Phase 1rhPSMA-7.3
Prostate CancerClinical Trials (1)
NCT03995888Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer
Phase 118F-Fluciclovine
GliomaClinical Trials (1)
NCT05555550Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Phase 118F-fluciclovine
GliomaClinical Trials (1)
NCT04114370Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma
Phase 118F-fluciclovine
Bladder CancerClinical Trials (1)
NCT0401805318Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Phase 1lutetium
Metastatic Prostate CancerClinical Trials (1)
NCT06516510A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Phase 118F fluciclovine
Brain MetastasesClinical Trials (1)
NCT0604809418F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Phase 1flotufolastat F 18
Prostate CancerClinical Trials (1)
NCT07069465Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging
Phase 118F fluciclovine
Brain Metastases, AdultClinical Trials (1)
NCT04689048Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
Phase 118F-Fluciclovine PET-MRI
GliomaClinical Trials (1)
NCT0555304118F-Fluciclovine PET-MRI in High-grade Glioma
Phase 1[18F]FLT
Brain TumorClinical Trials (1)
NCT03276676[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
Phase 1/2Arm A: 177Lu rhPSMA-10.1
Prostate CancerClinical Trials (1)
NCT06066437NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT07414940ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
Phase 1/2Lutetium
Prostate CancerClinical Trials (1)
NCT05413850Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Phase 1/2[18F]FPyQCP
Colorectal CancerClinical Trials (1)
NCT07432633[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 1/218F-fluciclovine PET Scan
Metastatic Castration-resistant Prostate CancerClinical Trials (1)
NCT0415824518F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
Phase 218F-Fluciclovine
Brain MetastasesClinical Trials (1)
NCT05554302Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Phase 2rhPSMA-7.3
Prostatic NeoplasmsClinical Trials (1)
NCT07285057Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Phase 2PET/CT with F-Fluciclovine
Brain Tumor, Recurrent, AdultClinical Trials (1)
NCT0392567518F-Fluciclovine PET and Multiparametric MR Imaging
Phase 218F-Fluciclovine
Brain MetastasesClinical Trials (1)
NCT06055790Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
Phase 2Computed Tomography
Prostate CarcinomaClinical Trials (1)
NCT07185165An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Phase 2PET/CT, PET/MRI, mpMRI
Prostate CarcinomaClinical Trials (1)
NCT02002455Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI
Phase 2Positron Emission Tomography
Prostate AdenocarcinomaClinical Trials (1)
NCT04175431Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
Phase 2PSMA PET/CT
Intermediate Risk Prostate CancerClinical Trials (1)
NCT07393867Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Phase 2Fluciclovine PET guided Radiotherapy
Newly Diagnosed GlioblastomaClinical Trials (1)
NCT04840069Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
Phase 218F fluciclovine
Brain Metastases18F-rhPSMA-7.3
Prostate Cancer (Post Prostatectomy)Clinical Trials (1)
NCT06617481PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Phase 2Leuprolide
Prostate CancerClinical Trials (1)
NCT07455903Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Phase 218F-Fluciclovine
Prostate CancerClinical Trials (1)
NCT03263780High Resolution PET-MRI Before Prostate Cancer HIFU
Phase 2Furosemide
Prostate AdenocarcinomaClinical Trials (1)
NCT05779943Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer
Phase 2FACBC PET-CT
Prostate CancerClinical Trials (1)
NCT02830880FACBC Prostate Therapy Response
Phase 2rhPSMA-7.3
Prostate CancerClinical Trials (1)
NCT04186819Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Phase 318F-Labeled Positron Emission Tomography
Prostate CancerClinical Trials (1)
NCT05678322Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy
Phase 3F-Fluciclovine radiotracer
Brain MetastasisClinical Trials (1)
NCT0615933518F-FLUC PET/MR in Patients With Brain Mets
Phase 3rhPSMA-7.3
Prostate CancerClinical Trials (1)
NCT04186845Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence
Phase 318F fluciclovine
Brain MetastasesrhPSMA-7.3
Prostate CancerClinical Trials (1)
NCT05799248Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
Phase 318F-fluciclovine PET CT
Prostate CancerClinical Trials (1)
NCT0268004118F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment
Phase 3PET imaging with 18F fluciclovine
Grade III or Grade IV GliomaClinical Trials (1)
NCT0547913618F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 48 clinical trials
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 3 crawl cycles